DSFIR Stock Overview
Provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for DSFIR from our risk checks.
DSM-Firmenich AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €117.10 |
| 52 Week High | €119.30 |
| 52 Week Low | €75.45 |
| Beta | 0 |
| 11 Month Change | 8.03% |
| 3 Month Change | 11.95% |
| 1 Year Change | 32.98% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -0.56% |
Recent News & Updates
DSM-Firmenich AG's (AMS:DSFIR) Shareholders Might Be Looking For Exit
Jun 20
Calculating The Intrinsic Value Of DSM-Firmenich AG (AMS:DSFIR)
May 24Here's Why DSM-Firmenich (AMS:DSFIR) Can Afford Some Debt
Apr 27Recent updates
DSM-Firmenich AG's (AMS:DSFIR) Shareholders Might Be Looking For Exit
Jun 20Calculating The Intrinsic Value Of DSM-Firmenich AG (AMS:DSFIR)
May 24Here's Why DSM-Firmenich (AMS:DSFIR) Can Afford Some Debt
Apr 27DSM-Firmenich AG (AMS:DSFIR) Shares Could Be 31% Below Their Intrinsic Value Estimate
Feb 18DSM-Firmenich AG's (AMS:DSFIR) Share Price Could Signal Some Risk
Dec 24Are Investors Undervaluing DSM-Firmenich AG (AMS:DSFIR) By 23%?
Nov 19Getting In Cheap On DSM-Firmenich AG (AMS:DSFIR) Is Unlikely
Sep 10Shareholder Returns
| DSFIR | NL Chemicals | NL Market | |
|---|---|---|---|
| 7D | 5.3% | 3.4% | 0.7% |
| 1Y | 33.0% | 7.8% | 11.6% |
Return vs Industry: DSFIR exceeded the Dutch Chemicals industry which returned 7.8% over the past year.
Return vs Market: DSFIR exceeded the Dutch Market which returned 11.6% over the past year.
Price Volatility
| DSFIR volatility | |
|---|---|
| DSFIR Average Weekly Movement | 3.3% |
| Chemicals Industry Average Movement | 3.1% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in NL Market | 6.9% |
| 10% least volatile stocks in NL Market | 2.3% |
Stable Share Price: DSFIR has not had significant price volatility in the past 3 months.
Volatility Over Time: DSFIR's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1902 | 27,926 | Dimitri de Vreeze | www.dsm-firmenich.com |
DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. It operates through Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients.
DSM-Firmenich AG Fundamentals Summary
| DSFIR fundamental statistics | |
|---|---|
| Market cap | €31.06b |
| Earnings (TTM) | -€190.00m |
| Revenue (TTM) | €12.46b |
2.5x
P/S Ratio-163.5x
P/E RatioIs DSFIR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DSFIR income statement (TTM) | |
|---|---|
| Revenue | €12.46b |
| Cost of Revenue | €9.07b |
| Gross Profit | €3.39b |
| Other Expenses | €3.58b |
| Earnings | -€190.00m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 13, 2025
| Earnings per share (EPS) | -0.72 |
| Gross Margin | 27.19% |
| Net Profit Margin | -1.53% |
| Debt/Equity Ratio | 20.6% |
How did DSFIR perform over the long term?
See historical performance and comparison